OC
CLNN icon

Oppenheimer & Co’s Clene CLNN Stock Holding History

Oppenheimer & Co’s Portfolio CLNN Stock Details CLNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,476
Closed -$83K – 1366
2022
Q3 		$83K Sell
1,476
-125
-8% -$8.28K ﹤0.01% 1309
2022
Q2 		$81K Buy
1,601
+342
+27% +$19.1K ﹤0.01% 1345
2022
Q1 		$99K Buy
1,259
+148
+13% +$8.95K ﹤0.01% 1415
2021
Q4 		$91K Buy
+1,111
New +$119K ﹤0.01% 1449

Other funds holding CLNN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIA
Soltis Investment Advisors St. George, Utah $1.59B AUM 23.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Oppenheimer & Co's CLNN Position: Q4 2022 in Review

Oppenheimer & Co sold out of Clene (CLNN) in Q4 2022, closing a stake of 1,476 shares — an estimated $83K sold.

Oppenheimer & Co first reported a position in CLNN in Q4 2021 and held it in 4 quarters. The position peaked at $99K in Q1 2022. 35 funds tracked by Wall St. Rank hold CLNN as of Q4 2022.

  • Oppenheimer & Co reported no remaining Clene position as of Q4 2022 after selling out during the quarter.
  • Oppenheimer & Co sold 1,476 Clene shares in Q4 2022, an estimated $83K.
  • Oppenheimer & Co first reported a position in Clene in Q4 2021 and held it in 4 quarters.
  • Oppenheimer & Co's Clene position peaked at $99K in Q1 2022.
  • 35 funds tracked by Wall St. Rank held Clene as of Q4 2022.

Based on Oppenheimer & Co's 13F filing for Q4 2022, filed 8 Feb 2023.